What Are the Key Statistics About Gestational Trophoblastic Disease?

Gestational trophoblastic (jeh-STAY-shuh-nul troh-fuh-BLAS-tik) disease (GTD) occurs in about 1 pregnancy out of 1,000 in the United States. Most of these are hydatidiform (HY-duh-TIH-dih-form) moles.

Choriocarcinoma (KOR-ee-oh-KAR-sih-NOH-muh), a malignant form of gestational trophoblastic disease (GTD), is even less common, affecting around 2 to 7 of every 100,000 pregnancies in the United States.

Choriocarcinoma and other forms of GTD are more common in many Asian and African countries.

Overall, gestational trophoblastic tumors account for less than 1% of female reproductive system cancers.

Cure rates depend on the type of GTD and its stage, as described in “ Treatment of gestational trophoblastic disease by type and stage.”

The American Cancer Society medical and editorial content team
Our team is made up of doctors and master’s-prepared nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.

Last Medical Review: February 6, 2014 Last Revised: February 9, 2016

American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.